Li-Na Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Li-Na Li has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Ang-Ran Fan
School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, People’s Republic of China
1 shared publication- Bo Zhang
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, People’s Republic of China
1 shared publication Haifeng Cui
Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China
1 shared publication- Hongsheng Chang
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China
1 shared publication Jie Wan
Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China
1 shared publicationJing Liu
Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China
1 shared publication
Latest Publications
- Open Access
- 1 March 2022
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 16, 843-861
Antidepressant-Like Effect and Mechanism of Ginsenoside Rd on Rodent Models of Depression
Background: There is growing evidence to suggest that ginsenoside Rd (GRd) has a therapeutic effect on depression, but the specific mechanisms behind its activity require further study. Objective: This study is designed to investigate the antidepressant-like effect and underlying mechanisms of GRd. Methods: In this study, the behavioral despair mouse model of depression and chronic unpredictable mild stress (CUMS) rat model of depression were established to explore the effects of GRd on depression-like behavior and its underlying mechanisms. Behavioral tests were used to evaluate the replication of animal models and depression-like behaviors. The hypoxia-inducible factor-1α (HIF-1α) blocker 2-methoxyestradiol (2-ME) was injected to determine the role of HIF-1α in the antidepressant-like effect of GRd. In addition, molecular biology techniques were used to determine the mRNA and protein expression of HIF-1ɑ signaling pathway and synaptic plasticity-related regulators, that is synapsin 1 (SYN 1) and postsynaptic density protein 95 (PSD 95). In silico binding interaction studies of GRd with focused target proteins were performed using molecular docking to predict the affinity and optimal binding mode between ligands and receptors. Results: Our data show that GRd significantly reversed depression-like behavior and promoted mRNA and protein expression of HIF-1ɑ signaling pathway and synaptic plasticity-related regulators. However, the antidepressant-like effect of GRd disappeared upon inhibition of HIF-1α expression following administration of 2-ME. Furthermore, molecular docking results showed that GRd possessed significant binding affinity for HIF-1α, VEGF, and VEGFR-2. Conclusion: Our results show that GRd exhibits significant antidepressant-like effect and that HIF-1α signaling pathway is a promising target for the treatment of depression.
- 1 March 2022
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 16, 843-861
Open AccessAntidepressant-Like Effect and Mechanism of Ginsenoside Rd on Rodent Models of Depression
Background: There is growing evidence to suggest that ginsenoside Rd (GRd) has a therapeutic effect on depression, but the specific mechanisms behind its activity require further study. Objective: This study is designed to investigate the antidepressant-like effect and underlying mechanisms of GRd. Methods: In this study, the behavioral despair mouse model of depression and chronic unpredictable mild stress (CUMS) rat model of depression were established to explore the effects of GRd on depression-like behavior and its underlying mechanisms. Behavioral tests were used to evaluate the replication of animal models and depression-like behaviors. The hypoxia-inducible factor-1α (HIF-1α) blocker 2-methoxyestradiol (2-ME) was injected to determine the role of HIF-1α in the antidepressant-like effect of GRd. In addition, molecular biology techniques were used to determine the mRNA and protein expression of HIF-1ɑ signaling pathway and synaptic plasticity-related regulators, that is synapsin 1 (SYN 1) and postsynaptic density protein 95 (PSD 95). In silico binding interaction studies of GRd with focused target proteins were performed using molecular docking to predict the affinity and optimal binding mode between ligands and receptors. Results: Our data show that GRd significantly reversed depression-like behavior and promoted mRNA and protein expression of HIF-1ɑ signaling pathway and synaptic plasticity-related regulators. However, the antidepressant-like effect of GRd disappeared upon inhibition of HIF-1α expression following administration of 2-ME. Furthermore, molecular docking results showed that GRd possessed significant binding affinity for HIF-1α, VEGF, and VEGFR-2. Conclusion: Our results show that GRd exhibits significant antidepressant-like effect and that HIF-1α signaling pathway is a promising target for the treatment of depression.
- Open Access
- 1 January 2017
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 7517358
Astragalus Granule Prevents Ca2+ Current Remodeling in Heart Failure by the Downregulation of CaMKII
Background. Astragalus was broadly used for treating heart failure (HF) and arrhythmias in East Asia for thousands of years. Astragalus granule (AG), extracted from Astragalus, shows beneficial effect on the treatment of HF in clinical research. We hypothesized that administration of AG prevents the remodeling of L‐type Ca2+ current (ICa-L) in HF mice by the downregulation of Ca2+/calmodulin‐dependent protein kinase II (CaMKII). Methods. HF mice were induced by thoracic aortic constriction (TAC). After 4 weeks of AG treatment, cardiac function and QT interval were evaluated. Single cardiac ventricular myocyte was then isolated and whole‐cell patch clamp was used to record action potential (AP) and ICa-L. The expressions of L‐type calcium channel alpha 1C subunit (Cav1.2), CaMKII, and phosphorylated protein kinase A (p‐PKA) were examined by western blot. Results. The failing heart manifested distinct electrical remodeling including prolonged repolarization time and altered ICa-L kinetics. AG treatment attenuated this electrical remodeling, supported by AG‐related shortened repolarization time, decreased peak ICa-L, accelerated ICa-L inactivation, and positive frequency‐dependent ICa-L facilitation. In addition, AG treatment suppressed the overexpression of CaMKII, but not p‐PKA, in the failing heart. Conclusion. AG treatment protected the failing heart against electrical remodeling and ICa-L remodeling by downregulating CaMKII.
- 1 January 2017
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 7517358
Open AccessAstragalus Granule Prevents Ca2+ Current Remodeling in Heart Failure by the Downregulation of CaMKII
Background. Astragalus was broadly used for treating heart failure (HF) and arrhythmias in East Asia for thousands of years. Astragalus granule (AG), extracted from Astragalus, shows beneficial effect on the treatment of HF in clinical research. We hypothesized that administration of AG prevents the remodeling of L‐type Ca2+ current (ICa-L) in HF mice by the downregulation of Ca2+/calmodulin‐dependent protein kinase II (CaMKII). Methods. HF mice were induced by thoracic aortic constriction (TAC). After 4 weeks of AG treatment, cardiac function and QT interval were evaluated. Single cardiac ventricular myocyte was then isolated and whole‐cell patch clamp was used to record action potential (AP) and ICa-L. The expressions of L‐type calcium channel alpha 1C subunit (Cav1.2), CaMKII, and phosphorylated protein kinase A (p‐PKA) were examined by western blot. Results. The failing heart manifested distinct electrical remodeling including prolonged repolarization time and altered ICa-L kinetics. AG treatment attenuated this electrical remodeling, supported by AG‐related shortened repolarization time, decreased peak ICa-L, accelerated ICa-L inactivation, and positive frequency‐dependent ICa-L facilitation. In addition, AG treatment suppressed the overexpression of CaMKII, but not p‐PKA, in the failing heart. Conclusion. AG treatment protected the failing heart against electrical remodeling and ICa-L remodeling by downregulating CaMKII.